PK Study of Liquid Formulation of BIO89-100 in Subjects With NASH With Compensation Cirrhosis

Key Inclusion Criteria: * Age 21 to 65 * Diagnosis of NASH with compensated cirrhosis by a hepatologist based on Liver Forum criteria. * Model for End-Stage Liver Disease (MELD) score \< 12. * Child-Turcotte-Pugh (CTP) score \< 7 (Class A). * Fibrosis stage F4 by FibroScan. Key Exclusion Criteria: * History of hepatic cirrhosis decompensation, OR overt hepatic encephalopathy OR signs of hepatic cirrhosis decompensation. * Prior transjugular intrahepatic portosystemic (TIPS) shunt procedure. * known condition other than cirrhosis that may possibly interfere with drug absorption, distribution, metabolism, or excretion. * Significant alcohol consumption for a period of more than 3 consecutive months within 1 year prior to screening.